Constipation affects roughly half of everyone living with Parkinson's disease, and in 2026 the treatment path is clearer than it has ever been: fiber, fluids, and scheduled toileting first, then polyethylene glycol (Miralax), then prescription options such as lubiprostone, linaclotide, or prucalopride. A 2022 systematic review in European Neurology pooled the studies and found prevalence around 51–54%, making constipation one of the most common non-motor symptoms of the disease.
It also matters more than comfort. Slowed gut transit interferes with levodopa absorption, so an untreated bowel problem can look like a medication problem. This guide covers what the evidence supports, the order in which to try treatments, and the warning signs that mean it is time for urgent care.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why Parkinson's causes constipation — often years before diagnosis
- What to try first: the stepwise approach
- Which medications actually have Parkinson's-specific evidence?
- The levodopa connection: why treating your gut can improve your motor symptoms
- Warning signs that need urgent care
- Frequently Asked Questions
Why Parkinson's causes constipation — often years before diagnosis
Parkinson's disease damages the nerves that drive the digestive tract, not just the ones that control movement. The colon moves stool more slowly, the muscles of the pelvic floor coordinate less well, and the stomach itself empties late. The result is infrequent, hard stools and a feeling of incomplete emptying. The timing is striking.
Research published in Scientific Reports and a Journal of Parkinson's Disease review found that 24–48% of patients report constipation before any motor symptom appears — in some cases as much as 20 years earlier. Constipation is now recognized as a prodromal marker, meaning an early signal that precedes the tremor, stiffness, and slowness that lead to diagnosis. For someone already diagnosed, this history matters mainly as reassurance: constipation is part of the disease itself, not a personal failing or simply a side effect of aging. That said, some medications — particularly anticholinergic drugs — make it worse, so a medication review belongs in any workup.
What to try first: the stepwise approach
The 2024 multidisciplinary consensus recommendations in Parkinsonism and Related Disorders lay out a clear sequence. Start with measures that cost nothing and carry no drug interactions, and escalate only if they fail.
The consensus reserves stimulants for later steps because the gut can become dependent on them, while polyethylene glycol is safe for daily long-term use. Caregivers can help most with the routine parts: keeping a fluid schedule, protecting the daily toilet time, and tracking bowel movements so the neurologist has real numbers rather than impressions.
- Step 1: Dietary fiber, adequate fluids, physical activity, and scheduled toileting — sitting on the toilet at the same time daily, ideally 20–30 minutes after a meal, when the gut is naturally most active.
- Step 2: Polyethylene glycol (Miralax), an osmotic laxative that draws water into the stool.
- Step 3: Stool softeners and, if needed, stimulant laxatives such as senna or bisacodyl — with prolonged stimulant use discouraged.
Which medications actually have Parkinson's-specific evidence?
Polyethylene glycol is the best-tested option in this population. A placebo-controlled trial in Movement Disorders followed 57 Parkinson's patients for 8 weeks and found macrogol (the same drug, under its international name) significantly improved responder rates, bowel-movement frequency, and stool consistency versus placebo. Lubiprostone, a prescription drug that increases fluid secretion in the intestine, also improved constipation in a double-blind placebo-controlled Parkinson's trial when titrated up to 48 μg per day. The Movement Disorder Society's Evidence-Based Medicine Committee rates both drugs as possibly useful, and an npj Parkinson's Disease review notes that macrogol is often preferred simply on cost, since neither has shown superiority over the other.
When osmotic laxatives fail, two second-line prescription options have data in parkinsonism: linaclotide, which works through the gut's guanylate cyclase-C pathway, and prucalopride, a serotonin-receptor prokinetic that speeds transit. In a parkinsonism cohort reported in Movement Disorders Clinical Practice, both significantly increased weekly bowel movements, and 71.4% of patients who did not respond to prucalopride improved after switching to linaclotide — useful to know before concluding that nothing works. Probiotics sit lower on the evidence ladder. Randomized trials through 2025, including a 74-participant multi-strain trial in Movement Disorders, show increased defecation frequency, but a Frontiers meta-analysis rates the overall evidence quality as low with high heterogeneity. They are reasonable to try but are not a guideline first-line treatment.
📨 Get Free Parkinson's Guides Alerts
Free · No spam · Unsubscribe anytime
The levodopa connection: why treating your gut can improve your motor symptoms
Levodopa is absorbed in the small intestine, and it only gets there when the stomach empties. Delayed gastric emptying affects over 70% of Parkinson's patients, according to a 2023 review in the European Journal of Neurology, and the result is "delayed-on" episodes — a dose that takes far too long to kick in — or "no-on" episodes where a dose seems to do nothing at all. This changes how to interpret erratic medication response.
Before assuming a levodopa dose needs to go up, it is worth asking whether the gut is delivering the drug at all. Treating constipation and slow transit can make existing doses work more predictably. The practical implication: mention bowel habits at every neurology visit, even if the appointment is nominally about tremor or dosing. The two systems are not separate problems.
Warning signs that need urgent care
Severe constipation in Parkinson's can progress silently to fecal impaction, megacolon, bowel obstruction, or perforation. The Parkinson's Foundation and the American Parkinson Disease Association advise emergency care when a constipated person develops any of the following: That last sign is the one families most often misread. Liquid stool escaping around a hard blockage looks like the opposite of constipation, and treating it with anti-diarrheal medication makes the impaction worse.
Anyone with days of no bowel movement followed by sudden leakage should be evaluated rather than medicated at home. A final medication note: anticholinergic drugs — used for tremor, bladder symptoms, and in some over-the-counter sleep aids — worsen constipation. Ask a pharmacist or the prescribing doctor to flag any anticholinergics on the current list before adding another laxative on top.
- Significant abdominal bloating
- Severe abdominal pain
- Vomiting
- New fecal incontinence — leakage around an impaction can masquerade as diarrhea
Frequently Asked Questions
How long should I try Miralax before asking about prescription options?
The trial evidence for polyethylene glycol ran 8 weeks. If daily use at the labeled dose has not produced regular, comfortable bowel movements within several weeks, bring it up with your neurologist — linaclotide and prucalopride both have supporting data in parkinsonism as next steps.
Is it safe to take a stimulant laxative like senna every day?
The 2024 consensus recommendations discourage prolonged stimulant use and place stimulants in the later steps of treatment. Daily long-term use is appropriate for polyethylene glycol, not senna or bisacodyl.
My levodopa doses have become unreliable — could constipation be the reason?
Possibly. Delayed gastric emptying affects over 70% of Parkinson's patients and can produce delayed-on or no-on episodes by holding the drug back from the small intestine, where it is absorbed. Raise both issues together with your neurologist before any dose change.
You Might Also Like
- How to Verify Diet and Nutrition for Parkinson’s Disease Claims in 2026: NIH, FDA, and trial records, Evidence, and Red Flags
- Diet and Nutrition for Parkinson’s Disease Explained for 2026: Who It Affects, Key Evidence, and What to Do Next
- Swallowing Problems Parkinson’s Update 2026: Evidence and Open Questions